Welcome to LookChem.com Sign In|Join Free
  • or
C10H23ClN2O5Pt is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

172275-73-9

Post Buying Request

172275-73-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

172275-73-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 172275-73-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,2,7 and 5 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 172275-73:
(8*1)+(7*7)+(6*2)+(5*2)+(4*7)+(3*5)+(2*7)+(1*3)=139
139 % 10 = 9
So 172275-73-9 is a valid CAS Registry Number.

172275-73-9Upstream product

172275-73-9Downstream Products

172275-73-9Relevant academic research and scientific papers

A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological Conditions

Kastner, Alexander,Poetsch, Isabella,Mayr, Josef,Burda, Jaroslav V.,Roller, Alexander,Heffeter, Petra,Keppler, Bernhard K.,Kowol, Christian R.

, p. 7464 - 7469 (2019)

Due to their high kinetic inertness and consequently reduced side reactions with biomolecules, PtIV complexes are considered to define the future of anticancer platinum drugs. The aqueous stability of a series of biscarboxylato PtIV complexes was studied under physiologically relevant conditions. Unexpectedly and in contrast to the current chemical understanding, especially oxaliplatin and satraplatin complexes underwent fast hydrolysis in equatorial position (even in cell culture medium and serum). Notably, the resulting hydrolysis products strongly differ in their reduction kinetics, a crucial parameter for the activation of PtIV drugs, which also changes the anticancer potential of the compounds in cell culture. The discovery that intact PtIV complexes can hydrolyze at equatorial position contradicts the dogma on the general kinetic inertness of PtIV compounds and needs to be considered in the screening and design for novel platinum-based anticancer drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 172275-73-9